13F reference period
Q2 2026
Security Snapshot
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) Institutional Ownership
CUSIP: 670002401
13F Institutional Holders and Ownership History from Q2 2016 to Q3 2026
Institutions Reporting
266
Shares (Excl. Options)
117.4M
Full value: 117,404,807 · shares · 30 Jun 2026Price
$9.42
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, Par Value $0.01 per share
- Symbol
- NVAX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 117,404,807
- Total 13F value
- $1,105,743,664
- Portfolio coverage rank
- 0%
- Share change
- -330,337
- Value change
- +$1,142,812
- Number of holders
- 266
- Shares outstanding
- 164,968,483
- SEC-reported price per share
- $12.66
- Insider filing price
- $12.66
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share is tracked under CUSIP 670002401.
- 266 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 258 to 266 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$960.69M
Full value: $960,689,630 · USD · 31 Mar 2026.$1.11B
Full value: $1,105,743,664 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 266 institutions filings for Q2 2026.
Security key
670002401
13F reference period
Q2 2026
13F holders
266
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
NVAX full holder history
NOVAVAX INC SEC filings
NOVAVAX INC company facts
NOVAVAX INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 670002401:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
NVAX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.4% | $90,252,258 | 13,450,411 | BlackRock, Inc. | 31 Dec 2024 | |||
| STATE STREET CORP | 7.1% | +20% | $109,539,481 | +$20,683,864 | 11,740,566 | +23% | STATE STREET CORPORATION | 30 Jun 2026 |
| SHAH CAPITAL MANAGEMENT | 6.5% | -29% | $115,204,978 | -$45,230,684 | 10,656,964 | -28% | Himanshu H. Shah | 16 Oct 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $67,608,243 | 8,305,681 | Vanguard Capital Management | 31 Mar 2026 | |||
| BANK OF AMERICA CORP /DE/ | 4.1% | -20% | $54,174,940 | -$13,513,474 | 6,655,398 | -20% | BANK OF AMERICA CORP /DE/ | 31 Mar 2026 |
As of 30 Jun 2026,
266
institutional investors reported holding
shares of
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX).
This represents
71%
of the company’s total
outstanding shares.
117.4M
Full value: 117,404,807 · shares · 30 Jun 2026164.97M
Full value: 164,968,483 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
62%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SHAH CAPITAL MANAGEMENT | 8.6% | 14,165,577 | -4.6% | 25% | $133,439,735 |
| BlackRock, Inc. | 8.5% | 13,946,881 | +8.6% | 0% | $131,379,618 |
| STATE STREET CORP | 7.1% | 11,740,550 | +31% | 0% | $110,595,981 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.6% | 7,607,996 | +6.4% | 0% | $71,667,322 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 7,257,449 | +1.8% | 0% | $68,365,170 |
| Sanofi | 4.2% | 6,880,481 | 0% | 12% | $64,814,131 |
| D. E. Shaw & Co., Inc. | 3.4% | 5,650,905 | -27% | 0.03% | $53,231,525 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 4,207,370 | +7.9% | 0% | $39,641,825 |
| TWO SIGMA INVESTMENTS, LP | 2.5% | 4,091,043 | +565% | 0.03% | $38,537,625 |
| COATUE MANAGEMENT LLC | 2.3% | 3,836,986 | 0% | 0.07% | $36,144,408 |
| BANK OF AMERICA CORP /DE/ | 2.1% | 3,416,235 | -49% | 0% | $32,180,934 |
| GOLDMAN SACHS GROUP INC | 1.8% | 3,007,756 | +113% | 0% | $28,333,064 |
| UBS Group AG | 1.1% | 1,869,659 | -58% | 0% | $17,612,188 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 1,768,163 | -54% | 0.01% | $16,656,095 |
| CITADEL ADVISORS LLC | 1% | 1,695,313 | +51% | 0.01% | $15,969,848 |
| Allianz Asset Management GmbH | 0.96% | 1,579,200 | -15% | 0.01% | $14,876,064 |
| NORTHERN TRUST CORP | 0.88% | 1,448,108 | -4.1% | 0% | $13,641,178 |
| TSP Capital Management Group, LLC | 0.86% | 1,419,365 | 3.2% | $13,370,420 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.82% | 1,346,607 | -2% | 0% | $12,685,038 |
| VANGUARD FIDUCIARY TRUST CO | 0.66% | 1,085,100 | -2% | 0% | $10,221,642 |
| JUPITER ASSET MANAGEMENT LTD | 0.65% | 1,070,232 | 0.05% | $10,081,585 | |
| AQR CAPITAL MANAGEMENT LLC | 0.55% | 902,650 | +706% | 0% | $8,502,964 |
| Bank of New York Mellon Corp | 0.52% | 849,718 | +8.8% | 0% | $8,004,342 |
| FEDERATED HERMES, INC. | 0.43% | 703,006 | +14691% | 0.01% | $6,622,316 |
| Point72 Asset Management, L.P. | 0.4% | 664,286 | -56% | 0.01% | $6,257,574 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
34
Headline period
Q2 2026
Rows shown
1-25 of 34
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 14,474,566 | $156,472,283 | -$20,055,498 | $10.81 | 51 |
| 2026 Q2 | 117,404,807 | $1,105,743,664 | +$1,142,812 | $9.42 | 266 |
| 2026 Q1 | 118,050,047 | $960,689,630 | +$3,963,831 | $8.14 | 258 |
| 2025 Q4 | 117,927,374 | $792,495,092 | +$80,703,799 | $6.72 | 233 |
| 2025 Q3 | 103,212,737 | $894,644,529 | +$22,681,191 | $8.67 | 244 |
| 2025 Q2 | 101,926,921 | $642,596,235 | +$26,723,556 | $6.30 | 245 |
| 2025 Q1 | 98,489,289 | $631,402,819 | -$31,743,582 | $6.41 | 239 |
| 2024 Q4 | 102,621,538 | $825,131,401 | -$12,498,087 | $8.04 | 226 |
| 2024 Q3 | 93,728,334 | $1,185,512,029 | +$128,224,618 | $12.63 | 225 |
| 2024 Q2 | 83,464,759 | $1,059,918,322 | +$101,312,152 | $12.66 | 220 |
| 2024 Q1 | 75,527,682 | $361,018,382 | -$3,812,627 | $4.78 | 189 |
| 2023 Q4 | 76,725,820 | $368,301,338 | +$60,349,311 | $4.80 | 191 |
| 2023 Q3 | 61,747,470 | $447,039,158 | +$35,454,803 | $7.24 | 218 |
| 2023 Q2 | 56,705,546 | $421,251,592 | -$21,077,107 | $7.43 | 202 |
| 2023 Q1 | 60,022,038 | $415,977,902 | +$24,129,521 | $6.93 | 208 |
| 2022 Q4 | 52,556,924 | $540,013,841 | +$137,141,602 | $10.28 | 236 |
| 2022 Q3 | 36,188,483 | $658,924,088 | -$41,541,447 | $18.20 | 214 |
| 2022 Q2 | 33,896,260 | $1,743,667,465 | -$19,484,059 | $51.43 | 288 |
| 2022 Q1 | 33,373,084 | $2,458,716,103 | -$55,536,369 | $73.65 | 346 |
| 2021 Q4 | 33,397,602 | $4,783,479,130 | -$707,719,453 | $143.07 | 399 |
| 2021 Q3 | 37,367,414 | $7,745,430,573 | -$523,926,966 | $207.31 | 412 |
| 2021 Q2 | 39,714,489 | $8,429,599,286 | -$519,994,166 | $212.31 | 394 |
| 2021 Q1 | 42,385,643 | $7,684,705,204 | +$831,207,087 | $181.31 | 369 |
| 2020 Q4 | 38,737,001 | $4,320,546,392 | +$723,829,689 | $111.51 | 327 |
| 2020 Q3 | 32,274,360 | $3,495,919,877 | +$140,194,009 | $108.35 | 299 |